Clinical Trials
All Clinical Trials - Page 15 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05931380Phase 3Completed
A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease
Orforglipron
- NCT05924256Phase 2Active Not Recruiting
A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing
Gonadorelin
- NCT06005012Phase 2Unknown
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
Semaglutide
- NCT06139419Phase 2Active Not Recruiting
The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC
Thymosin-Alpha-1
- NCT05936151Phase 2Completed
A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Retatrutide
- NCT05959096Phase 1Completed
A Study of LY3437943 in Healthy Participants With a High Body Mass Index
Retatrutide
- NCT05067621Phase 2Active Not Recruiting
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
Semaglutide
- NCT05916560Phase 1Completed
A Study of LY3437943 in Participants With Impaired and Normal Liver Function
Retatrutide
- NCT05936138Phase 1Completed
A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.
Orforglipron
- NCT05929079Phase 3Active Not Recruiting
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
Retatrutide
- NCT05929066Phase 3Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Retatrutide
- NCT05950516Phase 3Unknown
Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes
Semaglutide
- NCT05812183Phase 4Withdrawn
Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity
Tirzepatide
- NCT05726227Phase 3Active Not Recruiting
A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
Semaglutide
- NCT05891587Phase 2Completed
Semaglutide Therapy for Alcohol Reduction - Tulsa
Semaglutide
- NCT05872022N/AEnrolling By Invitation
A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy
Semaglutide
- NCT06354101N/AWithdrawn
The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.
Tirzepatide
- NCT06219330N/ACompleted
Cathelicidin LL-37 Relation to Potentially Malignant Lesions
Ll-37
- NCT06497049Phase 1Completed
Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.
Semaglutide
- NCT05891496Phase 3Completed
A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease
Semaglutide
- NCT05925959N/ARecruiting
Preoperative Weight Loss for Open Abdominal Wall Reconstruction
Semaglutide
- NCT06154486N/ACompleted
Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study
Semaglutide
- NCT05895643Phase 2Completed
Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?
Semaglutide
- NCT05882032Phase 1Completed
A Study of LY3502970 in Participants With Impaired and Normal Liver Function
Orforglipron
- NCT05888961N/ARecruiting
Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials
Ghrp-6
- NCT06120556N/ACompleted
Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes
Semaglutide
- NCT07104461N/ACompleted
Advanced Protein-based Program for Effective Treatment of Appetite Regulation and Obesity
Ghrp-6
- NCT05869903Phase 3Active Not Recruiting
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Orforglipron
- NCT05872620Phase 3Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Orforglipron
- NCT05756764N/AActive Not Recruiting
Anti-obesity Pharmacotherapy and Inflammation
Tirzepatide
- NCT06182618N/AUnknown
Retrospective Analysis for Patients With Metabolic Syndrome
Semaglutide
- NCT05898321N/AUnknown
To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone
Gonadorelin
- NCT06118008Phase 2Completed
A Study of HS-20094 in T2DM Participants
Semaglutide
- NCT05882045Phase 3Active Not Recruiting
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Retatrutide
- NCT07644897Phase 2Recruiting
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
Thymosin-Alpha-1
- NCT05793450Phase 1Completed
Pharmacokinetics of IBI362 in Subjects With and Without Renal Impairment
Mazdutide
- NCT05832060N/AUnknown
Comparing the Efficacy of tDCS and tRNS to Improve Reading Skills in Children and Adolescents With Dyslexia
Selank
- NCT05681299Phase 4Recruiting
Effects of GH and Lirglutide on AgRP
Liraglutide
- NCT05209165Phase 4Suspended
Semaglutide to Reduce Atrial Fibrillation Burden
Semaglutide
- NCT05835089N/AUnknown
Evaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney Diseases
Kisspeptin
- NCT05856630Phase 1Unknown
Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg
Gonadorelin
- NCT05870462Phase 4Unknown
Semaglutide and Vascular Regeneration
Semaglutide
- NCT05841238Phase 1Completed
A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants
Orforglipron
- NCT05268237Phase 1/Phase 2Recruiting
Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT05822544Phase 1Recruiting
Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes
Tirzepatide
- NCT05822830Phase 3Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
Tirzepatide
- NCT06215196N/ACompleted
Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesity
Semaglutide
- NCT05630586Phase 2Recruiting
Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke
Semaglutide
- NCT05804162Phase 1Completed
A Research Study Looking at How Cagrilintide Works on the Heart Rhythm in Healthy Participants
Cagrilintide
- NCT05482789Phase 4Recruiting
Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
Exenatide